Showing results (231-240 of 248) with videos related to

Sort By:
Pageof 25
The Journal of Clinical Endocrinology and Metabolism|February 23, 2010
Development of a sensitive and specific quantitative reverse transcription-polymerase chain reaction assay for blood thyroglobulin messenger ribonucleic acid in the follow-up of patients with differentiated thyroid carcinomaValter T Boldarine, Rui M B Maciel, Gustavo S Guimarães, et al.
Thyroid : Official Journal of the American Thyroid Association|September 2, 2025
Do Prognostic Differences Exist Among High-Risk RET Mutations? A Comparison of Outcomes Between the RET C634R and Other C634 Mutations in Hereditary Medullary Thyroid CarcinomaJie Zhang, Luciana Audi Castroneves, Susan C Lindsey, et al.
Archives of Endocrinology and Metabolism|November 6, 2025
Effect of radioiodine treatment for Graves' disease on the generation of TSH anti-receptor stimulating antibodies (TSI)Lia B Fiorin, Teresa S Kasamatsu, Cléber P Camacho, et al.
Thyroid : Official Journal of the American Thyroid Association|December 25, 2012
Measurement of calcitonin and calcitonin gene-related peptide mRNA refines the management of patients with medullary thyroid cancer and may replace calcitonin-stimulation testsCléber P Camacho, Susan C Lindsey, Maria Clara C Melo, et al.
Arquivos Brasileiros De Endocrinologia E Metabologia|June 5, 2007
[Diagnosis of metastases in patients with papillary thyroid cancer by the measurement of thyroglobulin in fine needle aspirate]Rosa Paula M Biscolla, Elza S Ikejiri, Maria Conceição Mamone, et al.
Archives of Endocrinology and Metabolism|June 26, 2023
Risk of malignancy and diagnostic accuracy of fine-needle aspiration biopsy in thyroid nodules with diameters greater than 4 centimetersRafaela N Barcelos, Cléber P Camacho, Maria da Conceição de O C Mamone, et al.
Endocrine-Related Cancer|November 4, 2016
M918V RET mutation causes familial medullary thyroid carcinoma: study of 8 affected kindredsM Cecília Martins-Costa, Lucas L Cunha, Susan C Lindsey, et al.
European Thyroid Journal|May 22, 2014
Basal serum thyroglobulin measured by a second-generation assay is equivalent to stimulated thyroglobulin in identifying metastases in patients with differentiated thyroid cancer with low or intermediate risk of recurrenceCláudia C D Nakabashi, Teresa S Kasamatsu, Felipe Crispim, et al.
Transboundary and Emerging Diseases|May 17, 2021
No molecular evidence of SARS-CoV-2 infection in companion animals from Veracruz, MexicoSokani Sánchez-Montes, Gerardo G Ballados-González, Janete Gamboa-Prieto, et al.
Plos One|November 4, 2021
Mortality and evolution between community and hospital-acquired COVID-AKIJonathan S Chávez-Íñiguez, José H Cano-Cervantes, Pablo Maggiani-Aguilera, et al.
Pageof 25